Sanofi & GSK Report Positive Preliminary Booster Data For COVID-19 Vaccine Candidate
15/12 08:11
(RTTNews) - Sanofi (SNYNF, SNY) and GSK (GSK.L, GSK) said preliminary results from the VAT0002 clinical trial showed that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate resulted in an increase of 9- to 43-fold in neutralizing antibodies regardles...